PR Newswire - SECuRE trial update: 92% of pre-chemo participants...
HIGHLIGHTS Safety Review Committee (SRC) meeting confirms end of the Dose Escalation Phase and commencement of the Cohort Expansion Phase (Phase II stage) of the SECuRE study. Based on the eff...
Read More

ภาษาไทย
English